| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 185.557 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 175.734 | 82 |
| GSM780709 | Untreated after 4 days (C3_1) | 133.686 | 79 |
| GSM780719 | Untreated after 4 days (C1_2) | 168.242 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 162.835 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 142.189 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 184.156 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 174.291 | 82 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 194.744 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 163.5 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 192.618 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 213.794 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 149.898 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 170.297 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 217.843 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 149.18 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 170.368 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 194.982 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 191.515 | 83 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 197.545 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 190.805 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 199.987 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 201.264 | 84 |